腸源性膿毒癥并發肺毛細血管滲漏綜合征一例救治_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

黃增相 ¹ ,  何超 ² , 陶驊 ¹ , 徐雯 ¹ , 徐迅科 ¹ , 金姝 ¹ , 魏建東 ¹ , 張健 ¹ , 李文放 ² , 林兆奮 ²

1. ;
2. ;

Corresponding?author：

何超, Email: hechao19820110@163.com

Keywords：

DOI：

10.7507/1671-6205.2015025

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 黃增相, 何超, 陶驊, 徐雯, 徐迅科, 金姝, 魏建東, 張健, 李文放, 林兆奮. 腸源性膿毒癥并發肺毛細血管滲漏綜合征一例救治. Chinese Journal of Respiratory and Critical Care Medicine, 2015, 14(1): 98-100. doi: 10.7507/1671-6205.2015025 Copy

1.	Moran JL, Graham PL, Rocklif S, et al.Updating the evidence for the role of corticosteroids in severe sepsis and septic shock:a Bayesian meta analytic perspective.Crit Care, 2010, 14:R134.
2.	Marx G.Fluid therapy in sepsis with capillary leakage.Eur J Anaesthesiol, 2003, 20:429-442.
3.	Masuda T, Sato K, Noda C, et al.Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion.Crit Care Med, 2003, 34:1987-1992.
4.	Kobayashi H, Suzuki M, Tanaka Y, et al.Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C and MEK/ERK/c-Jun-dependent signaling pathways.J Biol Chem, 2001, 276:2015-2022.
5.	趙曉琴, 吳英林, 鄺曉聰.烏司他丁對急性肺損傷保護作用的實驗研究.中國危重病急救醫學, 2008, 20:369-370.
6.	Isobe H, Okajima K, Uchiba M, et al.Inhibition of tumor necrosis factor production by urinary trypsin inhibitor.Int Congress Series, 2003, 1255:69-74.
7.	Nakatani K, Takea S, Tsujimoto H, et al.Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury.Leukoc Biol, 2001, 69:241-247.
8.	陳昊, 張麗葳, 林兆奮, 等.不同劑量烏司他丁對急性肺損傷大鼠MMP-9等炎癥因子調控的研究.中國醫藥導報, 2011, 8:15-18.
9.	王小偉, 韋世奎.不同劑量烏司他丁治療急性肺損傷的臨床研究.醫藥與保健, 2009, 17:51-52.
10.	陳曉兵, 許鐵, 陳雪峰, 等.不同劑量烏司他丁對感染性休克兔肺損傷的保護作用及其機制探討.臨床合理用藥, 2011, 4:8-12.
11.	Wilkes MM, Navickis RJ.Patient survival after human albumin administration.A meta-analysis of randomized controlled trials.Ann Intern Med, 2001, 135:149-164.
12.	Powers KA, Kapus A, Khadaroo RG, et al.Twenty-five percent albumain prevents lung injury following shock/resuscitation.Crit Care Med, 2003, 31:2355-2363.
13.	Rivers E, Nguyen B, Boyce N, et al.Early goal-directed resuscitation in sepsis and septic shock.N Engl J Med, 200l, 345:l368-1377.
14.	Martin GS, Moss M, Wheeler AP, et al.A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury.Crit Care Med, 2005, 33:1681-1687.
15.	何超, 李文放, 景炳文, 等.大劑量人血白蛋白快速滴注治療重度ARDS的臨床觀察.中國急救醫學雜志, 2011, 31:475-477.
16.	Quinlan GJ, Mumby S, Martin GS, et al.Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury.Crit Care Med, 2004, 32:755-759.
17.	景炳文.急危重病應用人血白蛋白的評價.內科急危重癥雜志, 2012, 18:194-198.
18.	何超, 庹素馨, 郁勝強, 等.狼瘡性腎炎并發肺重度毛細血管滲漏綜合征1例.中國急救醫學, 2010, 30:670-672.

1. Moran JL, Graham PL, Rocklif S, et al.Updating the evidence for the role of corticosteroids in severe sepsis and septic shock:a Bayesian meta analytic perspective.Crit Care, 2010, 14:R134.
2. Marx G.Fluid therapy in sepsis with capillary leakage.Eur J Anaesthesiol, 2003, 20:429-442.
3. Masuda T, Sato K, Noda C, et al.Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion.Crit Care Med, 2003, 34:1987-1992.
4. Kobayashi H, Suzuki M, Tanaka Y, et al.Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C and MEK/ERK/c-Jun-dependent signaling pathways.J Biol Chem, 2001, 276:2015-2022.
5. 趙曉琴, 吳英林, 鄺曉聰.烏司他丁對急性肺損傷保護作用的實驗研究.中國危重病急救醫學, 2008, 20:369-370.
6. Isobe H, Okajima K, Uchiba M, et al.Inhibition of tumor necrosis factor production by urinary trypsin inhibitor.Int Congress Series, 2003, 1255:69-74.
7. Nakatani K, Takea S, Tsujimoto H, et al.Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury.Leukoc Biol, 2001, 69:241-247.
8. 陳昊, 張麗葳, 林兆奮, 等.不同劑量烏司他丁對急性肺損傷大鼠MMP-9等炎癥因子調控的研究.中國醫藥導報, 2011, 8:15-18.
9. 王小偉, 韋世奎.不同劑量烏司他丁治療急性肺損傷的臨床研究.醫藥與保健, 2009, 17:51-52.
10. 陳曉兵, 許鐵, 陳雪峰, 等.不同劑量烏司他丁對感染性休克兔肺損傷的保護作用及其機制探討.臨床合理用藥, 2011, 4:8-12.
11. Wilkes MM, Navickis RJ.Patient survival after human albumin administration.A meta-analysis of randomized controlled trials.Ann Intern Med, 2001, 135:149-164.
12. Powers KA, Kapus A, Khadaroo RG, et al.Twenty-five percent albumain prevents lung injury following shock/resuscitation.Crit Care Med, 2003, 31:2355-2363.
13. Rivers E, Nguyen B, Boyce N, et al.Early goal-directed resuscitation in sepsis and septic shock.N Engl J Med, 200l, 345:l368-1377.
14. Martin GS, Moss M, Wheeler AP, et al.A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury.Crit Care Med, 2005, 33:1681-1687.
15. 何超, 李文放, 景炳文, 等.大劑量人血白蛋白快速滴注治療重度ARDS的臨床觀察.中國急救醫學雜志, 2011, 31:475-477.
16. Quinlan GJ, Mumby S, Martin GS, et al.Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury.Crit Care Med, 2004, 32:755-759.
17. 景炳文.急危重病應用人血白蛋白的評價.內科急危重癥雜志, 2012, 18:194-198.
18. 何超, 庹素馨, 郁勝強, 等.狼瘡性腎炎并發肺重度毛細血管滲漏綜合征1例.中國急救醫學, 2010, 30:670-672.

Previous Article
機械通氣聯合無抽搐電休克治療惡性綜合征并發重癥肺炎一例

Chinese Journal of Respiratory and Critical Care Medicine

腸源性膿毒癥并發肺毛細血管滲漏綜合征一例救治

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content